Is classical Hodgkin lymphoma aggressive?

Overview of classical Hodgkin lymphoma (cHL) Hodgkin lymphoma (HL) is potentially an aggressive (or fast growing) B-cell lymphoma. HL is characterised by the presence of very large cells called Reed-Sternberg (RS) cells, although other abnormal cell types may be present.

Can you live a long life with lymphoma?

The overall 5-year relative survival rate for people with NHL is 72%. But it’s important to keep in mind that survival rates can vary widely for different types and stages of lymphoma….5-year relative survival rates for NHL.

SEER Stage	5-Year Relative Survival Rate
Regional	90%
Distant	85%
All SEER stages combined	89%

Is there a new prognostic score for relapsed Hodgkin’s lymphoma?

New prognostic score based on treatment outcome of patients with relapsed Hodgkin’s lymphoma registered in the database of the German Hodgkin’s lymphoma study group. J Clin Oncol 2002;20:221–230.

What are the treatment options for relapsed or refractory aggressive lymphoma?

Bendamustine with rituximab, etoposide and carboplatin (T (R)EC) in relapsed or refractory aggressive lymphoma: a prospective multicentre phase 1/2 clinical trial. Br J Haematol 2018;183:601–607.

Where can I find the NCCN guidelines for Hodgkin lymphoma?

The National Comprehensive Cancer Network® (NCCN®) makes no representations or warranties of any kind regarding their content, use, or application and disclaims any responsibility for their application or use in any way. The complete NCCN Guidelines for Hodgkin Lymphoma are not printed in this issue of JNCCN but can be accessed online at NCCN.org.

What is the hd15 trial for Advanced Hodgkin’s lymphoma?

Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin’s lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial. Lancet 2012;379:1791–1799. Engert A, Haverkamp H, Kobe C, .